Favorable Media Coverage Somewhat Unlikely to Affect Humana (HUM) Share Price

News stories about Humana (NYSE:HUM) have trended positive recently, according to Accern. The research firm scores the sentiment of media coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Humana earned a news sentiment score of 0.25 on Accern’s scale. Accern also gave media headlines about the insurance provider an impact score of 45.4218147887497 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

Here are some of the news stories that may have effected Accern’s rankings:

Humana (HUM) traded up $3.03 on Friday, hitting $253.64. 2,019,865 shares of the company’s stock were exchanged, compared to its average volume of 1,360,000. The company has a market capitalization of $36,670.00, a price-to-earnings ratio of 21.38, a P/E/G ratio of 1.72 and a beta of 0.88. Humana has a fifty-two week low of $186.25 and a fifty-two week high of $264.56. The company has a current ratio of 1.61, a quick ratio of 1.61 and a debt-to-equity ratio of 0.35.

Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, November 8th. The insurance provider reported $3.39 earnings per share for the quarter, topping the Zacks’ consensus estimate of $3.27 by $0.12. The business had revenue of $13.28 billion during the quarter, compared to analyst estimates of $13.41 billion. Humana had a net margin of 3.49% and a return on equity of 15.99%. The company’s revenue was down 3.0% on a year-over-year basis. During the same period in the prior year, the business posted $3.18 earnings per share. equities research analysts expect that Humana will post 11.63 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Friday, January 26th. Shareholders of record on Friday, December 29th will be given a $0.40 dividend. The ex-dividend date is Thursday, December 28th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.63%. Humana’s payout ratio is currently 12.60%.

Humana declared that its board has authorized a share buyback program on Thursday, December 14th that permits the company to repurchase $3.00 billion in shares. This repurchase authorization permits the insurance provider to repurchase shares of its stock through open market purchases. Stock repurchase programs are usually an indication that the company’s board of directors believes its stock is undervalued.

A number of brokerages have commented on HUM. BidaskClub raised shares of Humana from a “sell” rating to a “hold” rating in a report on Wednesday, August 23rd. Cantor Fitzgerald reaffirmed a “hold” rating and set a $230.00 target price on shares of Humana in a report on Tuesday, December 5th. Cowen reaffirmed a “buy” rating and set a $285.00 target price on shares of Humana in a report on Wednesday. J P Morgan Chase & Co cut shares of Humana from an “overweight” rating to a “neutral” rating and set a $253.00 target price for the company. in a report on Monday, October 9th. Finally, ValuEngine cut shares of Humana from a “buy” rating to a “hold” rating in a report on Tuesday, October 10th. Twelve equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus target price of $256.30.

COPYRIGHT VIOLATION WARNING: This piece of content was posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece of content on another website, it was illegally stolen and republished in violation of United States and international trademark and copyright laws. The legal version of this piece of content can be accessed at https://www.dispatchtribunal.com/2017/12/16/favorable-media-coverage-somewhat-unlikely-to-affect-humana-hum-share-price.html.

About Humana

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Insider Buying and Selling by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply